Faculty profile

Amit Bhavsar

ResearcherMedical Microbiology and ImmunologyUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Alberta directory, so their publications, courses and email address may be missing. Find their university profile.

Signals and details

Research

bacterial ubiquitin ligase host-pathogen interactions innate immunity in planta expression mammalian cell culture pattern recognition receptors ubiquitin variants yeast heterologous expression

Latest funding

Canadian One Health Antimicrobial Resistance Health Research Training Network (CAN-AMR-Net)
CIHR · 2024 · Co-investigator
$2,700,000
Exploring variation at the Toll-like receptor 4 gene locus as a prognostic marker for cisplatin-induced hearing loss in childhood cancer patients
CIHR · 2023 · Supervisor
$105,000
Canada Research Chair - Tier 2
CIHR · 2021 · Nominated PI
$500,000

All 8 grants and awards

Canadian One Health Antimicrobial Resistance Health Research Training Network (CAN-AMR-Net)

Co-investigatorCIHR2024Training Grant: HRTP - One Health - Antimicrobial Resistance

Principal investigators: Barkema, Herman W; Cheng, Zhenyu; Lee, Amy H; Nguyen, Dao; Otto, Simon J; Wiktorowicz, Mary E

Keywords: Antimicrobial Resistance; Collaboration; Communication; Education; Employment Readiness; Experience; Highly-Qualified Personnel; Knowledge Transfer; One Health; Transdisciplinary

$2,700,000

Exploring variation at the Toll-like receptor 4 gene locus as a prognostic marker for cisplatin-induced hearing loss in childhood cancer patients

SupervisorCIHR2023Doctoral - PA - Canada Graduate Scholarship to Honor Nelson Mandela

Principal investigators: Latif, Asna

Keywords: Cell Culture; Crispr/Cas9; Genomics; Hearing Loss; Immunology; Paediatric Cancer; Pharmacology; Toxicity

$105,000

Canada Research Chair - Tier 2

Nominated PICIHR2021Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Bhavsar, Amit P

Keywords: Crc

$500,000

Advancing the therapeutic opportunity for TLR4 in reducing cisplatin-induced ototoxicity

Nominated PICIHR2021Project Grant

Principal investigators: Bhavsar, Amit P

Keywords: Chemotherapy-Related Toxicity; Childhood Cancer Treatment; Hearing Loss; Innate Immune Receptor; Innovative Pharmacological Agents; Otoprotectant Development; Small Molecule Screening

$956,250

Cross-kingdom platforms to study bacterial ubiquitin ligases in eukaryotic cells

Principal investigatorNSERC2020Discovery Grants Program - Individual

Principal investigators: Bhavsar, Amit

Keywords: bacterial ubiquitin ligase; host-pathogen interactions; pattern recognition receptors; innate immunity; ubiquitin variants; mammalian cell culture; yeast heterologous expression; in planta expression

$150,000

Cross-kingdom platforms to study bacterial ubiquitin ligases in eukaryotic cells

Principal investigatorNSERC2020Discovery Launch Supplement

Principal investigators: Bhavsar, Amit

$12,500

Mitigating cisplatin-induced ototoxicity in childhood cancer treatment through applied pharmacogenomics

Nominated PICIHR2017Op. Gr: NI grants in MRC&Y Health - M, R and Childhood and Adolescent Cancers

Principal investigators: Bhavsar, Amit P

Keywords: Adverse Drug Reactions; Cisplatin-Induced Ototoxicity; Gwas; Pediatric Oncology; Pharmacogenomics; Predictive Biomarker; Prophylaxis

$74,930

Canada Research Chair Tier 2

Nominated PICIHR2016Canada Research Chairs - CIHR Funded - Tier 2

Principal investigators: Bhavsar, Amit P

Keywords: Crc

$500,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction